Search Results - Merck Colombia

Calidad bacteriológica del agua de cuatro balnearios del municipio de Valledupar (Colombia).

Alternate Title: Bacteriological water quality for four recreational river spas in the municipality of Valledupar (Colombia).

Authors: Quintero-Corrales, Ana Fragoso-Castilla, Pedro J. Olivieri, Gino F.

Source: Información Tecnológica. Aug2021, Vol. 32 Issue 4, p31-38. 8p.

Análisis de variables físico-químicas en el proceso de remoción de coliformes en el sistema de lagunas de oxidación, Salguero, Valledupar (Colombia).

Alternate Title: Analysis of physico-chemical variables during coliform removal from the Salguero oxidation lagoon system, Valledupar (Colombia).

Authors: Fragoso-Castilla, Pedro J. Rubiano, Luis A. Kerguelen, José J.

Source: Información Tecnológica. Feb2021, Vol. 32 Issue 1, p113-122. 10p.

Antibiotic residues and microbial contamination in pasteurized whole milk intended for human consumption.

Authors: Londoño-Carmona, Juan Blandón-Escobar, Sandra Montoya-Zuluaga, John et al.

Source: Veterinary World. Mar2024, Vol. 17 Issue 3, p720-727. 8p.

Merck Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness

Authors: Merck

Source: Business Wire (English). 07/29/2013.

SEGURIDAD E INOCUIDAD ALIMENTARIA EN HOGARES DE JORNALEROS DE FINCAS CAFETERAS CON Y SIN CERTIFICACIÓN DEL SUROESTE DE ANTIOQUIA - COLOMBIA.

Alternate Title: FOOD SECURITY AND FOOD SAFETY IN HOUSEHOLDS OF DAY LABORERS IN CERTIFIED AND NON-CERTIFIED COFFEE FARMS AT THE SOUTHWEST OF ANTIOQUIA - COLOMBIA.

Authors: MANRIQUE CHICA, Oscar ROSIQUE GRACIA, Javier

Source: Vitae (01214004). 2014, Vol. 21 Issue 1, p20-29. 10p.

Correction: Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attendingselected healthcare institutions in Colombia.

Authors: Alvis-Guzman, Nelson Romero, Martín Salcedo-Mejia, Fernando et al.

Source: Diabetology & Metabolic Syndrome. 3/25/2024, Vol. 16 Issue 1, p1-1. 1p.

The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary event.

Authors: Zaratin P Samadzadeh S Seferoğlu M et al.

Source: Frontiers in neurology [Front Neurol] 2024 Jun 20; Vol. 15, pp. 1407257. Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE

Assessing the impact of childhood pneumococcal vaccination on pneumonia mortality in Colombia: a 14-year analysis.

Authors: Parellada, C. I. Reyes, L. F. Urrego-Reyes, J. et al.

Source: BMC Public Health. 9/1/2025, Vol. 25 Issue 1, p1-9. 9p.

Notizen aus der Wirtschaft. (German)

Authors: Bulmahn, Maren

Source: Nachrichten aus der Chemie; Apr2025, Vol. 73 Issue 4, p28-29, 2p

Bioavalaibility and pharmacokinetic comparison of two formulations of metformin 850 mg tablets in healthy Colombian volunteers.

Alternate Title: Comparación de la biodisponibilidad y la farmacocinética entre dos formulaciones de tabletas de metformina de 850 mg en voluntarios colombianos sanos.

Authors: HOLGUÍN, GLORIA CUESTA, FANNY ARCHBOLD, ROSENDO et al.

Source: Colombia Medica. ene-mar2011, Vol. 42 Issue 1, p81-87. 7p. 2 Charts, 1 Graph.

Subjects: ANALYSIS of variance, BIOAVAILABILITY, CONFIDENCE intervals, CROSSOVER trials, DIABETES, HIGH performance liquid chromatography, RESEARCH funding, STATISTICAL sampling, RANDOMIZED controlled trials, METFORMIN, BLIND experiment

Geographic Terms: COLOMBIA

Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study.

Authors: Colombo, Nicoletta Zsiros, Emese Parma, Gabriella et al.

Source: Lancet. Apr2026, Vol. 407 Issue 10538, p1525-1537. 13p.

Subjects: Pembrolizumab, Paclitaxel, Overall survival, Progression-free survival, Merck & Co. Inc., Adverse health care events, Ovarian cancer, Clinical trials, Immunotherapy

Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attending selected healthcare institutions in Colombia.

Authors: Alvis-Guzman, Nelson Romero, Martín Salcedo-Mejia, Fernando et al.

Source: Diabetology & Metabolic Syndrome. 2/15/2024, Vol. 16 Issue 1, p1-9. 9p.

PADF and Merck Launch Digital Data Platform on Maternal Mortality

Authors: Pan American Development Foundation

Source: Business Wire (English). 07/15/2015.

This result is not displayed to guests.
Login for full access.

The Onchocerciasis Elimination Program for the Americas (OEPA).

Authors: SAUERBREY, M.¹ oepa@oepa.net

Source: Annals of Tropical Medicine & Parasitology. 2008 Supplement 1, Vol. 102, p25-29. 5p.

$60.7 Million Worldwide Bioprocess Validation Industry to 2027 - Featuring Merck, Pall, Sartorius Stedim Biotech, SGS and Eurofins Scientific Among Others

Source: M2PressWIRE. 10/25/2022.

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.

Authors: Lorusso, Domenica Xiang, Yang Hasegawa, Kosei et al.

Source: Lancet. Apr2024, Vol. 403 Issue 10434, p1341-1350. 10p.

Subjects: Merck KGaA, Clinical trials, Merck & Co. Inc., Cervical cancer, External beam radiotherapy, Volumetric-modulated arc therapy, Chemoradiotherapy, Rectal cancer, Voice disorders

Cost-of-illness study of type 2 diabetes mellitus in Colombia.

Alternate Title: Diabetes mellitus tipo 2 en Colombia: costo de la enfermedad.

Authors: González, Juan Camilo Walker, John H. Einarson, Thomas R.

Source: Pan American Journal of Public Health. Jul2009, Vol. 26 Issue 1, p55-63. 9p. 1 Diagram, 7 Charts, 2 Graphs.

The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008–2019.

Authors: Pawaskar, Manjiri Gil-Rojas, Yaneth Irene Parellada, Cintia et al.

Source: Vaccine. Aug2022, Vol. 40 Issue 35, p5095-5102. 8p.

Making evidence, making legitimacy : the introduction of HPV (Human Papillomavirus) vaccines in Colombia

Authors: Maldonado Castañeda, Oscar Javier

Committee Members: Mort, Maggie; Roberts, Celia

URL: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.650800